Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors


Journal article


Sven Borchmann, Carolin Selenz, Mia Lohmann, Hanna Ludwig, Asmae Gassa, Johannes Brägelmann, Philipp Lohneis, Lydia Meder, Julia Mattlener, Sara Breid, Marieke Nill, Jana Fassunke, Amy J Wisdom, Anik Compes, Birgit Gathof, Hakan Alakus, David Kirsch, Khosro Hekmat, Reinhard Büttner, H Christian Reinhardt, Michael Hallek, Roland T Ullrich
Journal for Immuno Therapy of Cancer, 2022


Cite

Cite

APA   Click to copy
Borchmann, S., Selenz, C., Lohmann, M., Ludwig, H., Gassa, A., Brägelmann, J., … Ullrich, R. T. (2022). Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors. Journal for Immuno Therapy of Cancer. https://doi.org/10.1136/jitc-2022-004781


Chicago/Turabian   Click to copy
Borchmann, Sven, Carolin Selenz, Mia Lohmann, Hanna Ludwig, Asmae Gassa, Johannes Brägelmann, Philipp Lohneis, et al. “Tripartite Antigen-Agnostic Combination Immunotherapy Cures Established Poorly Immunogenic Tumors.” Journal for Immuno Therapy of Cancer (2022).


MLA   Click to copy
Borchmann, Sven, et al. “Tripartite Antigen-Agnostic Combination Immunotherapy Cures Established Poorly Immunogenic Tumors.” Journal for Immuno Therapy of Cancer, 2022, doi:10.1136/jitc-2022-004781.


BibTeX   Click to copy

@article{sven2022a,
  title = {Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors},
  year = {2022},
  journal = {Journal for Immuno Therapy of Cancer},
  doi = {10.1136/jitc-2022-004781},
  author = {Borchmann, Sven and Selenz, Carolin and Lohmann, Mia and Ludwig, Hanna and Gassa, Asmae and Brägelmann, Johannes and Lohneis, Philipp and Meder, Lydia and Mattlener, Julia and Breid, Sara and Nill, Marieke and Fassunke, Jana and Wisdom, Amy J and Compes, Anik and Gathof, Birgit and Alakus, Hakan and Kirsch, David and Hekmat, Khosro and Büttner, Reinhard and Reinhardt, H Christian and Hallek, Michael and Ullrich, Roland T}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in